KR101338901B9 - 육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물 - Google Patents

육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물

Info

Publication number
KR101338901B9
KR101338901B9 KR1020120025291A KR20120025291A KR101338901B9 KR 101338901 B9 KR101338901 B9 KR 101338901B9 KR 1020120025291 A KR1020120025291 A KR 1020120025291A KR 20120025291 A KR20120025291 A KR 20120025291A KR 101338901 B9 KR101338901 B9 KR 101338901B9
Authority
KR
South Korea
Prior art keywords
extract
treating
composition
vascular diseases
isolated therefrom
Prior art date
Application number
KR1020120025291A
Other languages
English (en)
Other versions
KR101338901B1 (ko
KR20130104103A (ko
Inventor
강건욱
오원근
Original Assignee
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교산학협력단 filed Critical 서울대학교산학협력단
Priority to KR1020120025291A priority Critical patent/KR101338901B1/ko
Publication of KR20130104103A publication Critical patent/KR20130104103A/ko
Application granted granted Critical
Publication of KR101338901B1 publication Critical patent/KR101338901B1/ko
Publication of KR101338901B9 publication Critical patent/KR101338901B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020120025291A 2012-03-13 2012-03-13 육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물 KR101338901B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120025291A KR101338901B1 (ko) 2012-03-13 2012-03-13 육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120025291A KR101338901B1 (ko) 2012-03-13 2012-03-13 육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물

Publications (3)

Publication Number Publication Date
KR20130104103A KR20130104103A (ko) 2013-09-25
KR101338901B1 KR101338901B1 (ko) 2014-01-07
KR101338901B9 true KR101338901B9 (ko) 2022-10-21

Family

ID=49453003

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120025291A KR101338901B1 (ko) 2012-03-13 2012-03-13 육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물

Country Status (1)

Country Link
KR (1) KR101338901B1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200067413A (ko) 2018-12-04 2020-06-12 경북대학교 산학협력단 육두구 에틸아세테이트 분획물을 유효성분으로 포함하는 심근경색증 예방 또는 치료용 조성물
KR102242195B1 (ko) 2020-06-16 2021-04-21 주식회사 웰니스바이오 비알코올성 지방간 질환의 개선, 예방 또는 치료용 조성물 및 그 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100679306B1 (ko) 2005-03-31 2007-02-06 아미코젠주식회사 리그난계 화합물을 함유하는 뇌신경질환의 치료 또는예방용 약학적 조성물
KR100830192B1 (ko) * 2005-09-22 2008-05-19 (주)바이오케어 메이스리그난 또는 이의 약제학적으로 허용 가능한 염을유효성분으로 함유하는 ＰＰＡＲα에 의해 매개되는 질환의예방 또는 치료용 조성물
KR101062670B1 (ko) * 2009-06-01 2011-09-06 (주)아모레퍼시픽 2,5-비스-아릴-3,4-디메틸테트라하이드로퓨란 리그난을 유효성분으로 포함하는 에이엠피케이의 활성화에 의해 매개되는 비만 관련 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
KR101338901B1 (ko) 2014-01-07
KR20130104103A (ko) 2013-09-25

Similar Documents

Publication Publication Date Title
HK1199220A1 (en) Pharmaceutical composition for the prevention or treatment of non- alcoholic fatty liver disease
EP2818482A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
PL2832365T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi wątroby
EP2824114A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
PL2818481T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi złośliwemu
EP2872151A4 (en) ACELLULAR PRO-TOLEROGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
PL2925757T3 (pl) Związki i kompozycje do leczenia chorób pasożytniczych
IL251083B (en) Compounds and preparations for the treatment of cancer
PL2685997T3 (pl) Kompozycja zawierająca ekstrakt kombinacji ziołowej do zapobiegania lub leczenia cukrzycowej neuropatii obwodowej
HK1215794A1 (zh) 用於治療疾病的同種異體自噬體富集組合物
HK1207579A1 (en) Composition for preventing or treating heart disease
KR101338901B9 (ko) 육두구 추출물 또는 이로부터 분리된 리그난계 화합물을 함유하는 혈관 질환의 예방 또는 치료용 조성물
EP2826488A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS
HK1213188A1 (zh) 用於消減腫瘤的嗜鹽菌提取物組合物
KR101451473B9 (ko) 강활 추출물을 유효성분으로 포함하는 당뇨병 치료 또는 예방용 조성물
EP2785342A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERTRIGLYCERIDEMIA OR DISEASES ASSOCIATED WITH HYPERTRIGLYCERIDEMIA
HK1157189A1 (en) Pharmaceutical composition for the treatment of tumor diseases

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161227

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20171124

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20181203

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191203

Year of fee payment: 7

G170 Re-publication after modification of scope of protection [patent]